Pigment Cell & Melanoma Research

Papers
(The median citation count of Pigment Cell & Melanoma Research is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information41
38
34
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing29
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy28
Cytoglobin functions as a redox regulator of melanogenesis in normal epidermal melanocytes27
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)27
SASH1 Mutations and Hereditary Disorders of Pigmentation: Review of Literature25
Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies24
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma21
Issue Information19
Let’s talk about sex: A biological variable in immune response against melanoma19
Issue Information18
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 617
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes17
25th International Pigment Cell Conference, Bilbao, Spain IPCC 202317
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma14
Issue Information14
Progress in melanoma treatment: Patient's perspectives14
Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma14
PASPCR 2024 Annual Meeting, New York, NY13
Issue Information13
The Melanocyte and Nerve Fiber Cross‐Talk, Facilitated Also by Semaphorin‐4A, Enhances UV‐B‐Induced Melanogenesis13
Corrigendum13
13
Corrigendum13
Abstracts13
The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma12
Issue Information12
Celebrating the life of James J. Nordlund, MD, a larger‐than‐life scholar, mentor, and friend11
Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling11
Sex Differences in Acral Lentiginous Melanoma: A Retrospective Cohort Analysis of 3617 Cases From the Surveillance, Epidemiology, and End Results Database10
Single‐cell profiling of MC1R‐inhibited melanocytes10
Cover Image9
9
BORIS/CTCFL‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells9
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population8
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma8
7
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models7
Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes7
7
Issue Information6
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐16
Cover Image6
Topical antibiotics limit depigmentation in a mouse model of vitiligo6
Dominant Negative Mitf Allele Impacts Melanophore and Xanthophore Development and Reveals Collaborative Interactions With Tfec in Zebrafish Chromatophore Lineages6
The delicate relation between melanocytes and skin immunity: A game of hide and seek6
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation6
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo6
Cover Image6
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 20236
Issue Information6
The Proposed Categorization of Vitiligo Lesions on the Hands5
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism5
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance5
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment5
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production5
2‐Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity5
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants5
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 20155
The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/65
Three‐dimensional imaging for the analysis of human epidermal melanocytes5
Pigmentation and Retinal Pigment Epithelium Thickness: A Study of the Phenotypic and Genotypic Relationships Between Ocular and Extraocular Pigmented Tissues5
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma5
The metabolism of melanin synthesis—From melanocytes to melanoma5
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model5
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment4
TFE3 promotes ferroptosis in melanoma4
4
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation4
ToFSIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma4
Advancements in melanoma cancer metastasis models4
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis4
Cutaneous Pigment Cell Distributions and Skin Structure of Xenopus4
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines4
Issue Information4
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab4
Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas4
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era4
Issue Information3
3
The classification of melanocytic gene signatures3
Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy3
RNA M6A modification shaping cutaneous melanoma tumor microenvironment and predicting immunotherapy response3
Association of Pretreatment Tumour Microenvironment and Treatment Outcome in Patients With Locally Advanced Melanoma Treated With Isolated Limb Perfusion3
Xenopus as a model system for studying pigmentation and pigmentary disorders3
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State3
3
Corrigendum3
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care3
3
An in vitro nevus explant model for studying the effects of ultraviolet radiation3
Myron Gordon Award Lecture 2023: Painting the neural crest: How studying pigment cells illuminates neural crest cell biology3
Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line3
Optimisation of skin phototype classification3
Interplay of Light, Melatonin, and Circadian Genes in Skin Pigmentation Regulation3
Primary cutaneous melanoma in Black patients: An analysis of 2464 cases from the National Cancer Database 2004–20183
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features3
Issue Information3
Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation3
New Dermoscopy Pattern in Nevus‐Associated Melanomas3
Protein‐based classification of melanoma differentiation subtypes2
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma2
Conjunctival Melanoma: A Narrative Review of Current Knowledge2
Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations2
Issue Information2
The Yucatan miniature swine as a model for post‐inflammatory hyperpigmentation2
The Role of Two Tyrosinase‐Like Glycoenzymes in Defining the Final Hue of Parrot Plumage2
AP‐3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio)2
Identification and functional assays of single‐nucleotide variants of opsins genes in melanocytic tumors2
The Neuro‐Endocrinal Regulation in Vitiligo2
A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment2
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study2
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas2
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities2
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage2
In Memoriam: Soldano Ferrone MD, PhD (1940–2023)2
Cover Image2
Piceatannol—Can It Be Used to Treat Hyperpigmentation of the Skin?2
Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)2
Low‐Dose Baricitinib Plus Narrow‐Band Ultraviolet B for the Treatment of Progressive Non‐Segmental Vitiligo: A Prospective, Controlled, Open‐Label Study2
Melanoma and Matrimony: Retrospective Study of Demographics, Marital Status, and Clinical Features of Patients With Acral Melanoma at a Single Academic Center2
Trained immunity in the pathogenesis of vitiligo2
X and Y Differences in Melanoma Survival Between the Sexes2
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort1
List of Reviewers for PCMR1
Epilogue1
1
Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series1
Cholinergic Signaling Mediated by Muscarinic Receptors Triggers the Ultraviolet‐Induced Release of Melanosome in Cultured Melanoma Cells1
Oncogenic properties via MAPK signaling of the SOX5‐RAF1 fusion gene identified in a wild‐typeNRAS/BRAF giant congenital nevus1
Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus‐like features1
Impact of Drug–Drug Interactions on Clinical Outcomes in Metastatic Melanoma Patients Treated With Combined BRAF/MEK Inhibitors: A Real‐World Study1
1
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)1
Clinicopathological features and associations in a series of South African acral melanomas1
The Incorporation of Melanosomes by Senescent Keratinocytes Causes the Accumulation of Melanin due to Decreased Energy Metabolism1
List of reviewers for PCMR (01.01.2023–30.09.2023)1
Genotypic spectrum of albinism in Mali1
Cover Image1
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis1
The 21st International Congress of the Society for Melanoma Research1
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants1
Issue Information0
0
MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells0
Molecular skin fluorescence imaging: A tool for evaluating early melanoma development0
A meta‐analysis of the placebo response in vitiligo: Causes and consequences for the interpretation of clinical trials0
Epidermotropic Metastatic Melanoma Presenting as Eruptive Primary Melanomas0
20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma research0
Phenotypic plasticity of melanocytes derived from human adult skin0
Issue Information0
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity0
Issue Information0
High‐Risk Melanoma: Stage Before Operating0
Twenty years of research in melanoma therapy–From “nothing works” to cures: A personal account0
0
Small extracellular vesicle‐based human melanocyte and melanoma signature0
Prognostic biomarkers for survival in mucosal melanoma0
The prognostic implications of cuproptosis‐related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma0
0
Diversity, equity, and inclusion in the melanoma research community0
Neurological Mechanisms Exploration and Therapeutic Targets in Segmental Vitiligo Accompanied by White Hair0
The role of ferroptosis in melanoma0
Issue Information0
The MITF regulatory network in melanoma0
25th Annual meeting of the European Society for Pigment Cell Research, Marseille, France0
The effect of oxidative degradation of Dopa‐melanin on its basic physicochemical properties and photoreactivity0
Issue Information0
Dynamic regulation of chromatin accessibility during melanocyte stem cell activation0
MITF E318K: A rare homozygous case with multiple primary melanoma0
Eosinophils and melanoma: Implications for immunotherapy0
Genetically engineered multicistronic allele of Pmel yielding highly specific CreERT2‐mediated recombination in the melanocyte lineage0
Brief history of the Society for Melanoma Research: A community of clinicians, researchers, and friends0
Curation of OCA2 Variants of Uncertain Significance From Chinese Oculocutaneous Albinism Patients Based on Multiplex Assays0
A Unique Signature for Cancer‐Associated Fibroblasts in Melanoma Metastases0
Prediagnostic serum 25‐hydroxyvitamin D and leptin in relation to melanoma‐specific death and overall death0
Quality Analysis of Measurement Properties of Patient‐Reported Outcome Measures for Vitiligo and of the Studies Assessing Them: A Systematic Review0
Disruption of mc1r Disturbs Skin Pigmentation in Xenopus tropicalis0
Nrf2 protein in melanoma progression, as a new means of treatment0
Interferon‐gamma induces melanogenesis via post‐translational regulation of tyrosinase0
Genetic insights into Tietz albinism‐deafness syndrome: A new dominant‐negative mutation in MITF0
Identification and characterization of the compound heterozygous variants of TYR gene in a northern Chinese family with Oculocutaneous albinism type 10
Overview of current melanoma therapies0
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer0
Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo0
List of reviewers for PCMR (01.01.2021–30.09.2021)0
Issue Information0
Unusual Autosomal Dominant Inheritance of Oculocutaneous Albinism Type 4 (OCA‐4): Clinical and Functional Features From A Chinese Family0
Beta‐Blockers and Cutaneous Melanoma Outcomes: A Systematic Review and Random‐Effects Meta‐Analysis0
In memoriam Beatrice Mintz (1921–2022)0
Alteration of Hair Melanin in Patients With Mowat–Wilson Syndrome: The Role of the ZEB2 Gene in Regulating Melanogenesis Through SLC45A20
A twenty year perspective on melanoma therapy0
Varicella‐zoster virus in actively spreading segmental vitiligo skin: Pathological, immunochemical, and ultrastructural findings (a first and preliminary study)0
Undereducation is afoot: Assessing the lack of acral lentiginous melanoma educational materials for skin of color0
0
Multi‐omics analysis reveals inflammatory biomarkers for skin melanoma prognosis0
Joining PCMR: Aspirations for Editorial Contributions0
Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment0
Effectiveness and Safety of Oral Compound Glycyrrhizin Followed by Phototherapy for the Treatment of Progressive Vitiligo in Children0
Seasonal variation in effect of anti‐PD‐1 initiation on overall survival among patients with advanced melanoma0
Next‐generation of melanoma researchers: Trainee perspectives from around the world0
Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage0
Systematic review and meta‐analysis of genomic alterations in acral melanoma0
Drosophila yellow‐h encodes dopaminechrome tautomerase: A new enzyme in the eumelanin biosynthetic pathway0
Comparative Transcriptome Analysis Reveals Differential Cutaneous Gene Expression in the Color Variation of Two Ornamental Discus, Red Melon and Red Cover0
PURPL Represses Radiation‐Induced Apoptosis to Promote Radioresistance in Cutaneous Melanoma by Direct Interfering With BID Cleavage0
19th International Congress of the Society for Melanoma Research0
Survival benefit of sentinel lymph node biopsy in Asian melanoma patients0
Revisiting the role of varicella zoster virus in segmental vitiligo0
Cell‐intrinsic melanin fails to protect melanocytes from ultraviolet‐mutagenesis in the absence of epidermal melanin0
Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross‐sectional study in 684 melanoma patients0
0
0
A Ball Python Colour Morph Implicates MC1R in Melanophore–Xanthophore Distribution and Pattern Formation0
Bay 11‐7082, an NFκB Inhibitor, Prevents Post‐Inflammatory Hyperpigmentation Through Inhibition of Inflammation and Melanogenesis0
Synonymous but Significant: New Findings of Pathological Variants in Hermansky–Pudlak Syndrome0
Conventional suspension delivery versus tattooing pen‐assisted suspension delivery in non‐cultured epidermal cell suspension procedure for vitiligo: A randomized controlled trial0
Vitiligo non‐responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentation0
PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels0
Activated Akt expression is associated with the recurrence of primary melanomas and further refines the prognostic and predictive values for relapse in acral melanomas0
NR2F1 regulates a Schwann cell precursor‐vs‐melanocyte cell fate switch in a mouse model of Waardenburg syndrome type IV0
A B‐cell or a key player? The different roles of B‐cells and antibodies in melanoma0
Issue Information0
Issue Information0
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti‐CTLA‐4 treatment0
Issue Information0
Database for queries of melanoma cohorts with molecular and clinical data0
Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma0
Uric acid is a major chemical constituent for the whitish coloration in the medaka leucophores0
New insights into the pathogenesis of Hermansky–Pudlak syndrome0
The MFSD12 p.Tyr182His common variant is sufficient to alter mouse agouti coat color0
Reconstructed human pigmented skin/epidermis models achieve epidermal pigmentation through melanocore transfer0
Photobiomodulation Using 830 nm Lighting‐Emitting Diode Inhibits Melanogenesis via FOXO3a in Human Melanocyte0
IPCC2023: Looking for translational opportunities by persevering in basic pigment cell research0
Cancer‐Associated Fibroblast Signature Can Predict Prognosis and Therapeutic Responses in Skin Cutaneous Melanoma0
Anti‐melanogenic effect of exosomes derived from human dermal fibroblasts (BJ‐5ta‐Ex) in C57BL/6 mice and B16F10 melanoma cells0
Image analysis systems to calculate the surface area of vitiligo lesions: A systematic review of measurement properties0
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL0
Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation0
Laser capture microdissection provides a novel molecular profile of human primary cutaneous melanoma0
MitoCur‐1 induces ferroptosis to reverse vemurafenib resistance in melanoma through inhibition of USP140
Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study0
Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first‐line anti‐programmed death‐1 monotherapy: A real‐world multicentre observational0
Issue Information0
Identification of melanoma‐specific exosomal miRNAs as the potential biomarker for canine oral melanoma0
Zebrafish as a new model for rhododendrol‐induced leukoderma0
Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications0
An In Vivo Study of LNS8801, a GPER Agonist, in a Spontaneous Melanoma‐Prone Mouse Model, TGS0
0.10713195800781